The phenotype of axial spondyloarthritis: is it dependent on HLA‐B27 status?

The phenotype of axial spondyloarthritis: is it dependent on HLA‐B27 status?

<p><strong>Objective:</strong> To describe the radiographic phenotype of axial spondyloarthritis (axSpA) according to the carriage of HLA‐B27.</p> <p><strong>Methods:</strong> An international collaboration compared the radiographic phenoty...

Full description

Bibliographic Details
Main Authors:	Coates, LC, Baraliakos, X, Blanco Garcia, F, Blanco-Morales, E, Braun, J, Chandran, V, Fernandez-Sueiro, JL, FitzGerald, O, Gallagher, P, Gladman, DD, Gubar, E, Korotaeva, T, Loginova, E, Lubrano, E, Mulero, J, Pinto, J, Queiro, R, Sanz, J, Szentpetery, A, Helliwell, PS
Format:	Journal article
Language:	English
Published:	Wiley 2020

Similar Items

Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in Phase 3 studies of tofacitinib
by: Coates, L, et al.
Published: (2021)

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
by: Smolen, JS, et al.
Published: (2017)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
by: Gladman, DD, et al.
Published: (2022)

SUCCESSFUL USE OF AN INTERLEUKIN 17 INHIBITOR (SECUKINUMAB) IN THE TREATMENT OF ISOLATED DESTRUCTIVE ENTHESITIS IN PSORIATIC ARTHRITIS
by: E. E. Gubar, et al.
Published: (2018-11-01)

Involvement of the axial skeleton in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2017-03-01)

What should be the primary target of "treat to target" in psoriatic arthritis?
by: Coates, LC, et al.
Published: (2018)

Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?
by: Braun, J, et al.
Published: (2023)

GRAPPA 2018 project report
by: Goel, N, et al.
Published: (2019)

Estimation of the sensitivity and specificity of ASAS criteria for peripheral spondyloarthritis in patients with early psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2015-09-01)

Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile
by: Rubén Queiro, et al.
Published: (2023-07-01)

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
by: Poddubnyy, D, et al.
Published: (2021)

Management of Axial Spondyloarthritis – Insights into Upadacitinib
by: Braun J, et al.
Published: (2022-10-01)

THE EARLY DIAGNOSIS AND CLINICAL FEATURES OF AXIAL SPONDYLOARTHRITIS AT THE EUROPEAN CONGRESS OF RHEUMATOLOGY 2015
by: E. E. Gubar, et al.
Published: (2016-09-01)

Prognostic factors associated with achieving minimal disease activity in early psoriatic arthritis patients treated according to “treat-to-target” st rategy within 12 months
by: E. Yu. Loginova, et al.
Published: (2022-12-01)

Progression of axial spondyloarthritis
by: Sh. F. Erdes, et al.
Published: (2021-06-01)

Outcomes of the 2019 GRAPPA workshop on continuous composite indices for the assessment of psoriatic arthritis and membership: Recommended next steps
by: Tillett, W, et al.
Published: (2020)

Characteristics of patients with psoriatic arthritis treated with ustekinumab. Evidence from real-life clinical practice
by: Yu. L. Korsakova, et al.
Published: (2021-01-01)

Experience in using secukinumab in patients with axial psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2020-11-01)

The genetic basis of spondyloarthritis: SPARTAN/IGAS 2009.
by: Evans, D, et al.
Published: (2010)

The Role of Imaging in Diagnosing Axial Spondyloarthritis
by: Nikita Khmelinskii, et al.
Published: (2018-04-01)

Non-Physical Disease Facets in Spondyloarthritis: An ASAS Health Index-Based Analysis between Psoriatic Arthritis and Axial Spondyloarthritis
by: Rubén Queiro, et al.
Published: (2022-10-01)

Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative
by: De Marco, G, et al.
Published: (2020)

Comparative characteristics of early psoriatic arthritis with and without axial skeleton injury (a subanalysis of the all-Russian registry of patients with psoriatic arthritis)
by: E. E. Gubar, et al.
Published: (2019-12-01)

Possibilities of screening for a high-risk axial skeletal lesion in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2020-09-01)

Axial involvement in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2022-12-01)

GRAPPA 2019 project report
by: Goel, N, et al.
Published: (2020)

Opening Lecture <subtitle>Novel Treatment Algorithms in Axial Spondyloarthritis — What is the Current Status?</subtitle>
by: Xenofon BARALIAKOS
Published: (2023-11-01)

EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE
by: E. Yu. Loginova, et al.
Published: (2020-06-01)

Psoriatic arthritis. Clinical guidelines for diagnosis and treatment
by: T. V. Korotaeva, et al.
Published: (2018-06-01)

Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
by: Helliwell, PS, et al.
Published: (2021)

The Genetic Basis of Spondyloarthritis: SPARTAN/IGAS 2009 (vol 37, pg 2626, 2010)
by: Evans, D, et al.
Published: (2011)

Sustained very low disease activity and remission in psoriatic arthritis patients
by: Lubrano, E, et al.
Published: (2019)

Inhibition of interleukin-17 in patients with oligoarticular psoriatic arthritis
by: Ogdie, A, et al.
Published: (2023)

Mesenchimal stem cells: a possible role in the pathogenesis and treatment of spondyloarthritis
by: F.M. Perrotta, et al.
Published: (2017-05-01)

The genetic basis of spondyloarthritis: SPARTAN/IGAS 2009 (Journal of Rheumatology (2010) 37 (2626-2631))
by: Evans, D, et al.
Published: (2011)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
by: Helliwell, PS, et al.
Published: (2022)

Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence
by: Jürgen Braun, et al.
Published: (2021-08-01)

CLINICAL AND INSTRUMENTAL CHARACTERISTICS OF AXIAL LESION IN EARLY PERIPHERAL PSORIATIC ARTHRITIS (DATA OF A REMARCA STUDY)
by: E. E. Gubar, et al.
Published: (2018-03-01)

2-years outcomes of the treat-to-target strategy in early psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2022-11-01)

A randomized, phase 3, double-blind trial examining methotrexate and etanercept as monotherapy or in combinstion for treating psoriatic arthritis: A comparison of the composite measures used to evaluate disease activity
by: Mease, PJ, et al.
Published: (2019)